Open AccessRisk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization
Author(s) -
Aaron P. Thrift,
Harvey A. Risch,
Lynn Onstad,
Nicholas J. Shaheen,
Alan G. Casson,
Leslie Bernstein,
Douglas A. Corley,
David M. Levine,
Wong Ho Chow,
Brian J. Reid,
Yvonne Romero,
Laura J. Hardie,
Geoffrey Liu,
Anna H. Wu,
Nigel C. Bird,
Marilie D. Gammon,
Weimin Ye,
David C. Whiteman,
Thomas L. Vaughan
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/rjts-tc75
Subject(s) - mendelian randomization , esophageal adenocarcinoma , randomization , medicine , oncology , mathematics , adenocarcinoma , biology , randomized controlled trial , genetics , gene , cancer , genetic variants , genotype